Cargando…

Statins and Inflammation: New Therapeutic Opportunities in Psychiatry

Statins, which are widely used to treat hypercholesterolemia, have anti-inflammatory and anti-oxidant effects. These are thought to be responsible for the potential effects of statins on various psychiatric disorders. In this study, we comprehensively review the literature to investigate the effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Sung-Wan, Kang, Hee-Ju, Jhon, Min, Kim, Ju-Wan, Lee, Ju-Yeon, Walker, Adam J., Agustini, Bruno, Kim, Jae-Min, Berk, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413672/
https://www.ncbi.nlm.nih.gov/pubmed/30890971
http://dx.doi.org/10.3389/fpsyt.2019.00103
_version_ 1783402865965924352
author Kim, Sung-Wan
Kang, Hee-Ju
Jhon, Min
Kim, Ju-Wan
Lee, Ju-Yeon
Walker, Adam J.
Agustini, Bruno
Kim, Jae-Min
Berk, Michael
author_facet Kim, Sung-Wan
Kang, Hee-Ju
Jhon, Min
Kim, Ju-Wan
Lee, Ju-Yeon
Walker, Adam J.
Agustini, Bruno
Kim, Jae-Min
Berk, Michael
author_sort Kim, Sung-Wan
collection PubMed
description Statins, which are widely used to treat hypercholesterolemia, have anti-inflammatory and anti-oxidant effects. These are thought to be responsible for the potential effects of statins on various psychiatric disorders. In this study, we comprehensively review the literature to investigate the effects of statins on various psychiatric disorders including depression, schizophrenia, and dementia. In addition, we review adverse effects and drug interactions of statins to give clinically useful information guiding statin use in the psychiatric field. Statins seem useful in reducing depression, particularly in patients with physical disorders such as cardiovascular disease. In patients with schizophrenia, negative symptoms may be reduced by adjuvant statin therapy. Studies on cohorts at risk for dementia have generally shown protective effects of statins, while those on treatment for dementia show inconsistent results. In conclusion, statins used in combination with conventional psychotropic medications may be effective for various psychiatric disorders including depression, schizophrenia, and dementia. Further study is required to determine optimal doses and duration of statin use for the treatment of psychiatric disorders.
format Online
Article
Text
id pubmed-6413672
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-64136722019-03-19 Statins and Inflammation: New Therapeutic Opportunities in Psychiatry Kim, Sung-Wan Kang, Hee-Ju Jhon, Min Kim, Ju-Wan Lee, Ju-Yeon Walker, Adam J. Agustini, Bruno Kim, Jae-Min Berk, Michael Front Psychiatry Psychiatry Statins, which are widely used to treat hypercholesterolemia, have anti-inflammatory and anti-oxidant effects. These are thought to be responsible for the potential effects of statins on various psychiatric disorders. In this study, we comprehensively review the literature to investigate the effects of statins on various psychiatric disorders including depression, schizophrenia, and dementia. In addition, we review adverse effects and drug interactions of statins to give clinically useful information guiding statin use in the psychiatric field. Statins seem useful in reducing depression, particularly in patients with physical disorders such as cardiovascular disease. In patients with schizophrenia, negative symptoms may be reduced by adjuvant statin therapy. Studies on cohorts at risk for dementia have generally shown protective effects of statins, while those on treatment for dementia show inconsistent results. In conclusion, statins used in combination with conventional psychotropic medications may be effective for various psychiatric disorders including depression, schizophrenia, and dementia. Further study is required to determine optimal doses and duration of statin use for the treatment of psychiatric disorders. Frontiers Media S.A. 2019-03-05 /pmc/articles/PMC6413672/ /pubmed/30890971 http://dx.doi.org/10.3389/fpsyt.2019.00103 Text en Copyright © 2019 Kim, Kang, Jhon, Kim, Lee, Walker, Agustini, Kim and Berk. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Kim, Sung-Wan
Kang, Hee-Ju
Jhon, Min
Kim, Ju-Wan
Lee, Ju-Yeon
Walker, Adam J.
Agustini, Bruno
Kim, Jae-Min
Berk, Michael
Statins and Inflammation: New Therapeutic Opportunities in Psychiatry
title Statins and Inflammation: New Therapeutic Opportunities in Psychiatry
title_full Statins and Inflammation: New Therapeutic Opportunities in Psychiatry
title_fullStr Statins and Inflammation: New Therapeutic Opportunities in Psychiatry
title_full_unstemmed Statins and Inflammation: New Therapeutic Opportunities in Psychiatry
title_short Statins and Inflammation: New Therapeutic Opportunities in Psychiatry
title_sort statins and inflammation: new therapeutic opportunities in psychiatry
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6413672/
https://www.ncbi.nlm.nih.gov/pubmed/30890971
http://dx.doi.org/10.3389/fpsyt.2019.00103
work_keys_str_mv AT kimsungwan statinsandinflammationnewtherapeuticopportunitiesinpsychiatry
AT kangheeju statinsandinflammationnewtherapeuticopportunitiesinpsychiatry
AT jhonmin statinsandinflammationnewtherapeuticopportunitiesinpsychiatry
AT kimjuwan statinsandinflammationnewtherapeuticopportunitiesinpsychiatry
AT leejuyeon statinsandinflammationnewtherapeuticopportunitiesinpsychiatry
AT walkeradamj statinsandinflammationnewtherapeuticopportunitiesinpsychiatry
AT agustinibruno statinsandinflammationnewtherapeuticopportunitiesinpsychiatry
AT kimjaemin statinsandinflammationnewtherapeuticopportunitiesinpsychiatry
AT berkmichael statinsandinflammationnewtherapeuticopportunitiesinpsychiatry